Research map: Glucagon-like Peptide-1 Receptor Agonists in Obese Left Ventricular Assist Device Recipients: A Propensity-Matched Real-World Cohort Study

Back to the article

Papers in this map

  1. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes · Steven P. Marso · 2016 · 7637 citations · Cited by this paper
  2. Anti-Obesity Medications Versus Metabolic Bariatric Surgery as Pathways to Heart Transplant Eligibility in LVAD-Supported Patients: A Narrative Review · Noah Sicouri · 2026 · Cites this paper
  3. Incidence and Mortality Outcomes of Extracorporeal Membrane Oxygenation in Infants With Congenital Lung Malformations: A Registry Study · 2026 · Related
  4. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes · Steven P. Marso · 2016 · 6910 citations · Cited by this paper
  5. HeartMate 3 in Pediatric and Complex Populations: Physiologic Rationale, Patient Selection, and Management Strategies · 2026 · Related
  6. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial · Hertzel C. Gerstein · 2019 · 3179 citations · Cited by this paper
  7. Redefining Limits: Extracorporeal Cardiopulmonary Resuscitation in Adult Thrombotic Thrombocytopenic Purpura · 2026 · Related
  8. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes · A. Michael Lincoff · 2023 · 3058 citations · Cited by this paper
  9. Quantitative Cerebral Perfusion Monitoring Using Transit-Time Flow Measurement During Neonatal Aortic Arch Surgery: A Case Report · 2026 · Related
  10. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1 · Daniel J. Drucker · 2018 · 2131 citations · Cited by this paper
  11. Outcomes of Temporary Right Ventricular Assist Device at the Time of Durable Left Ventricular Assist Device Implantation · 2026 · Related
  12. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity · Mikhail Kosiborod · 2023 · 1621 citations · Cited by this paper
  13. Novel Explantation Protocol for Cardiac Recovery and Device Weaning Post-Left Ventricular Assist Device Therapy: A Single-Center Experience · 2026 · Related
  14. Eighth annual INTERMACS report: Special focus on framing the impact of adverse events · James K. Kirklin · 2017 · 1262 citations · Cited by this paper
  15. In Vitro Tests of Antegrade Distal Limb Perfusion Modalities in Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation · 2026 · Related
  16. Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure · Mandeep R. Mehra · 2018 · 722 citations · Cited by this paper
  17. Venoarterial Extracorporeal Membrane Oxygenation Timing in Infarct-Related Cardiogenic Shock: Before Versus After Primary Percutaneous Coronary Intervention · 2026 · Related
  18. Acquired von Willebrand Syndrome After Continuous-Flow Mechanical Device Support Contributes to a High Prevalence of Bleeding During Long-Term Support and at the Time of Transplantation · Nir Y. Uriel · 2010 · 583 citations · Cited by this paper
  19. Incidence and Management of Gastrointestinal Bleeding With Continuous Flow Assist Devices · Ashim Aggarwal · 2012 · 206 citations · Cited by this paper
  20. Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials · Frederick Berro Rivera · 2024 · 149 citations · Cited by this paper
  21. Glucagon-like peptide-1 receptor agonists and pancreatitis: A meta-analysis of randomized clinical trials · Matteo Monami · 2014 · 105 citations · Cited by this paper
  22. Heart Failure and Obesity: The Latest Pandemic · Ebenezer Kobbie Aryee · 2023 · 97 citations · Cited by this paper
  23. Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits · Chi Kin Wong · 2025 · 96 citations · Cited by this paper
  24. Role of Glucagon‐Like Peptide‐1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity · Erin D. Michos · 2023 · 91 citations · Cited by this paper
  25. Association of Perioperative Glucagon-like Peptide-1 Receptor Agonist Use and Postoperative Outcomes · Seth Z. Aschen · 2024 · 56 citations · Cited by this paper
  26. Epidemiology of Left Ventricular Assist Device Infections: Findings From a Large Nonregistry Cohort · Merilda O. Blanco‐Guzman · 2020 · 36 citations · Cited by this paper
  27. Anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) in coronary artery disease: a comprehensive review · Alicja Skrobucha · 2024 · 31 citations · Cited by this paper
  28. The impact of extreme obesity on outcomes after left ventricular assist device implantation · Gardner L. Yost · 2017 · 27 citations · Cited by this paper
  29. Impact of Diabetes and Glycemia on Cardiac Improvement and Adverse Events Following Mechanical Circulatory Support · Christos P. Kyriakopoulos · 2024 · 8 citations · Cited by this paper
  30. Glucagon-like Peptide-1 Receptor Agonists in Heart Failure: Mechanisms, Evidence and Identifying Optimal Candidates · Magdy Abdelhamid · 2025 · 6 citations · Cited by this paper
  31. Bleeding and thrombotic complications and their impact on mortality in patients supported with left ventricular assist device for cardiogenic shock · Ingrid Bekono-Nessah · 2022 · 5 citations · Cited by this paper
  32. Low Driveline Infection Rates in Patients With a Novel Fully Magnetically Levitated Ventricular Assist Device · Xian-Qiang Wang · 2025 · 5 citations · Cited by this paper
  33. Clinical outcomes of modified left ventricular assist device driveline management · Shusuke Imaoka · 2024 · 4 citations · Cited by this paper
  34. Impact of severe obesity on heart transplantation outcomes: A meta-analysis of survival and complications · Ana Maria Bicudo Diniz · 2025 · 3 citations · Cited by this paper
  35. Targeting Obesity for Heart Failure · Emily Morris · 2025 · 3 citations · Cited by this paper
  36. Weight evolution after implantation of left ventricular assist device: Do we need to interfere? · Katrien Vandersmissen · 2020 · 1 citation · Cited by this paper
  37. Untitled · Cited by this paper
  38. Untitled · Cited by this paper

Source: OpenAlex (CC0)